4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-25-047725
Chief Financial Officer sold 4,864 shares at $2.84 ($13,814)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-27 | Sale : show line 1 in the form 10b5-1 | −298 | $2.84 | $846 | 379,133 | D |
| 2025-03-27 | Sale : show line 2 in the form 10b5-1 | −4,566 | $2.84 | $12,967 | 374,567 | D |
| Open-market sales · 4,864 sh · avg $2.84 · $13,814 | ||||||
Loading xslF345X05/ownership.xml…